Ms. Jensen joined the Company in 2014 and is currently Vice President of Clinical Development. From 2014 to 2016, she held positions of increasing responsibility in Progenics across clinical operations, program management, and clinical development. She is a multi-disciplined and dynamic leader, with over 10 years of oncology experience across all phases of clinical research. Prior to joining Progenics, Jessica advanced immunotherapy programs at the Ludwig Institute for Cancer Research where she led global clinical trials of combination therapies with immune checkpoint inhibitors and cancer vaccines. Prior thereto, Jessica led clinical operations activities for an orphan drug program at Gentium SpA, a biopharmaceutical company since acquired by Jazz Pharmaceuticals, and she supported client programs as well as the development of a contract research organization business unit at US Oncology. Jessica began her career in Statistical Programming and Biostatistics after receiving a Master of Public Health degree in Epidemiology & Biostatistics from the George Washington University. Ms. Jensen joined the Company in 2014 and is currently Vice President of Clinical Development. From 2014 to 2016, she held positions of increasing responsibility in Progenics across clinical operations, program management, and clinical development. She is a multi-disciplined and dynamic leader, with over 10 years of oncology experience across all phases of clinical research. Prior to joining Progenics, Jessica advanced immunotherapy programs at the Ludwig Institute for Cancer Research where she led global clinical trials of combination therapies with immune checkpoint inhibitors and cancer vaccines. Prior thereto, Jessica led clinical operations activities for an orphan drug program at Gentium SpA, a biopharmaceutical company since acquired by Jazz Pharmaceuticals, and she supported client programs as well as the development of a contract research organization business unit at US Oncology. Jessica began her career in Statistical Programming and Biostatistics after receiving a Master of Public Health degree in Epidemiology & Biostatistics from the George Washington University.

Clinical Development